EquityFlow
›
Companies
› Cellogen Therapeutics
Cellogen Therapeutics
Biotech
· IN
Cellular engineering startup developing affordable bispecific CAR-T and gene therapies.
Funding history
Date
Round
Amount
May 2026
Funding round
Cellogen Therapeutics raised ₹20 Cr (~$2M) from Kotak Life Sciences Fund I to advance its CAR-T clinical programs.
$2M
Investors
Kotak Alternate Asset Managers
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →